Nicotinamide N-methyltrasferase (NMMT) catalyzes the conversion of nicotinamide (NA) to 1-methylnicotinamide (MNA). Recent studies have reported that exogenous MNA exerts anti-thrombotic and anti-inflammatory activity, suggesting that endogenous NMMT-derived MNA may play a biological role in the cardiovascular system. In the present study, we assayed changes in hepatic NNMT activity and MNA plasma levels along the progression of atherosclerosis in apoE/LDLR -/-mice, as compared to age-matched wild-type mice. Atherosclerosis progression in apoE/LDLR -/-mice was quantified in aortic root, while hepatic NNMT activity and MNA plasma concentrations were concomitantly measured in 2-, 3-, 4-, and 6-month-old mice. In apoE/LDLR -/-mice, atherosclerotic plaques developed in the aortic roots beginning at the age of 3 months and gradually increased in size, macrophage content, and inflammation intensity over time, as detected by Oil-Red O staining, CD68 immunostaining, and in situ zymography (MMP2/MMP9 activity). Hepatic NNMT activity was upregulated approximately two-fold in apoE/LDLR -/-mice by the age of 2 months, as compared to wild-type mice (1.03 ± 0.14 vs. 0.64 ± 0.23 pmol/min/mg, respectively). MNA plasma concentrations were also elevated approximately two-fold (0.30 ± 0.13 vs. 0.17 ± 0.04 mmol/l, respectively). As atherosclerosis progressed, hepatic NMMT activity and MNA plasma concentrations increased five-fold in 6-month-old apoE/LDLR -/-mice at the stage of advanced atherosclerotic plaques (NMMT activity: 2.29 ± 0.34 pmol/min/mg, MNA concentration: 1.083 ± 0.33 mmol/l). In summary, the present study demonstrated that the progression of vascular inflammation and atherosclerosis was associated with the upregulation of hepatic NNMT activity and subsequent increase in endogenous MNA plasma levels. Given the anti-thrombotic and anti-inflammatory properties of exogenous MNA, robust activation of an endogenous NA-MNA pathway in atherosclerosis may play an important compensatory role.
Introduction
Nicotinamide N-methyltrasferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of methyl group of S-adenosylmethionine (SAM) to nicotinamide (NA) producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH) [3, 33] . NNMT activity is localized predominantly in the mammalian liver, but it can also be detected in the heart, placenta, lung, brain, adrenals, skeletal muscles, kidneys [3, 39] , adipose tissue [32] , and tumor cells [37] . NNMT also plays a role in the biotransformation of drugs, which undergo methylation via methyltransferases [26, 45] , but the physiological role of this enzyme appears to be linked to the activity of its major substrate -NA (niacin, vitamin B3), in addition to its major product -MNA. NA is a water-soluble vitamin essential for energy supply, cell viability, and resistance to stress or injury [28] . Moreover, it has recently become apparent that MNA, long considered an inactive metabolite of NA, possess anti-thrombotic [10] , antiinflammatory [8] , gastroprotective [9] , and vasoprotective [5] properties.
Interestingly, it has been reported that NNMT activity can be markedly increased in a range of different circumstances, for example, in rats treated with ligands for peroxisome proliferator activated receptor a (PPARa) [14] ; in mice treated with alkylating agents [30] or with phenobarbital [16] ; in hepatoma cells with expression of the hepatitis C virus core protein [27] ; in mouse models of bacteria-induced fulminant hepatitis [15] ; and in patients with liver cirrhosis [13, 31] or Parkinson's disease [4, 29] . Moreover, heightened NNMT activity was reported in many types of cancer cells, including papillary thyroid cancer cells [47] , renal carcinoma cells [49] , human stomach adenocarcinoma cells [23] , oral squamous carcinoma cells [38] , colorectal cancer cells [35] , and radio-resistant bladder cancer cells [24] . The upregulation of NMMT in cancer cells suggests a possible role for NMMT in tumor growth, migration, and metastasis [38, 46] . Indeed, it was hypothesized that NNMT activity in cancer cells or NNMT concentrations in serum may provide a useful biomarker in patients with cancer [35, 37] .
The NNMT gene has been cloned in both humans and mice [2, 48] . However, the biological significance of alterations in NNMT activity in various pathological conditions and the factors regulating NNMT expression remain largely unknown. It was recently demonstrated that NNMT gene expression in cancer cells may be regulated by the hepatocyte nuclear factor b (HNF-1b) binding to specific HNF-1 sites in the NNMT basal promoter region [47] , as well as by signal transducers and activators of transcription 3 (STAT3) [42] . It was also suggested that NNMT activity is determined by genetic polymorphisms. In contrast to others [6] , some authors [41] have demonstrated that NNMT's genetic polymorphisms influence the concentration of homocysteine in plasma. Furthermore, children with NNMT polymorphism, who have been exposed to medicines and/or a low nicotinamide diet, have an eight-fold increased risk of developing congenital heart defects [44] .
Finally, NNMT activity may be involved in regulating the biological activity of endogenous MNA. Recently, we suggested that MNA formed in the liver by nicotinamide N-methyltrasferase can be an endogenous activator of the COX-2/PGI 2 pathway and may play an important regulatory role in limiting thrombosis and inflammatory processes in the cardiovascular system [10] . The formation and progression of atherosclerotic plaques are driven by vascular inflammation and thrombosis, and both of these processes may be associated with changes in NNMTderived MNA formation. We tested this hypothesis in the present study and investigated whether hepatic NNMT activity and endogenous MNA plasma concentrations are altered along the progression of atherosclerosis in apoE/LDLR -/-mice.
Materials and Methods

Animals
ApoE/LDLR -/-mice on a C57BL/6J genetic background (obtained from The Jackson Laboratory, Maine, USA) and wild-type C57BL/6J mice were used in the study.
Pharmacological Reports, 2009, 61, 76-85
Mice were maintained on 12-h dark/12-h light cycles in air-conditioned rooms (22.5 ± 0.5°C, 50 ± 5% humidity) with access to standard chow diet and water ad libitum. All animal care procedures conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and were approved by the Jagiellonian University Ethics Committee on Animal Experiments.
ApoE/LDLR -/-and C57BL/6J mice at the age of 2, 3, 4, and 6 months (n = 6) were injected with 1000 IU of fraxiparine (Sanofi-Synthelabo, Santea, France) and anesthetized (10 mg/kg of thiopental ip Sandoz, Vienna, Austria). The entire heart was dissected, embedded in OCT-compound (Jung, Germany) and snap-frozen at -80°C to examine atherosclerosis progression. A liver sample (approximately 300 mg) was taken and washed with cold 0.9% (w/v) sodium chloride immediately after isolation to assess hepatic NMMT activity. To analyze the concentration of MNA and its metabolites in plasma, blood samples were taken from the left ventricle of the heart and centrifuged for 6 min (14,000 × g) to isolate plasma. Ten micrometer-thick sections of the aortic root were cut on a Leica CM1800 cryostat according to the standardized cross-section protocol previously described in detail [24] .
In short, serial sections from the proximal 1 mm of the aortic root were collected on separate slides, air dried, and fixed in 4% phosphate-buffered paraformaldehyde (oil red) or left unfixed and stored at -20°C (zymography/immunohistochemistry).
To assess lipid deposition, sections were stained with Oil Red-O (ORO) and examined under an Olympus BX50 microscope (Olympus, Tokyo, Japan). Images of the aortic roots were obtained using an Olympus DP71 digital CCD camera. The total lesion area, as revealed by ORO staining, was measured semiautomatically for each slide using the Zeiss LSM Image Browser 3.2 software (Carl Zeiss, Jena, Germany). The mean lesion area was calculated using a minimum of eight slices per animal.
To demonstrate [34] gelatinase activity in the zymography assay, non-fixed aorta sections were thawed and incubated for 2 h at 37 o C in a dark humid chamber with a reaction buffer containing 50 mg/ml of FITC-labeled DQ-gelatin (Molecular Probes, Eugene, OR, USA). Sections were rinsed in PBS, fixed in cold 4% paraformaldehyde for 15 min, placed on the mounting medium (Dako, Glostrup, Denmark) and observed using fluorescence microscopy. The peptide fluorescence released from FITC-gelatin is representative of local tissue gelatinase activity. Carl Zeiss AxioVision 4.6 software was used to measure the fluorescence intensity, which was measured in at least 3 sections from each aortic root sample.
For the indirect immunohistochemistry of macrophages, sections previously used for zymography were rinsed in PBS and preincubated with 5% normal goat serum with 2% dry milk. The sections were then incubated overnight with rat anti-mouse CD68 (Serotec, Oxford, UK; # MCA1957XZ; diluted 1:800), and then Cy3-conjugated goat anti-rat antiserum (Jackson IR, West Grove, PA) was applied. Sections were examined using an epifluorescence Olympus BX50 microscope equipped with appropriate filter cubes to show Cy3 (red) and FITC (green) fluorescence.
Determination of NNMT activity in the liver
To measure the activity of N-methyltransferase, the fluorometric method of Sano et al. [36] was used with a slight modification. The method was based on the enzyme reaction at pH 8.6 using 4-methylnicotinamide (4-MNA) as the methyl acceptor substrate in the presence of cofactor, S-adenosyl-L-methionine (SAM), and the fluorometric determination of the product, 1,4-dimethylnicotinamide, by means of its reaction with 4-methoxybenzaldehyde. The livers of mice were excised and washed with cold 0.9% (w/v) sodium chloride, immediately frozen in liquid nitrogen, and stored at -80°C. The tissue was homogenized 1:9 (w/v) in cold PBS buffer (pH 7.4) with a Teflon-glass homogenizer. The homogenate was centrifuged at 12,000 × g for 20 min at 4°C. The supernatant was used immediately to assay enzymatic activity. Protein concentration was determined using BSA as the standard. The reaction mixture consisted of 12 ml of 2 mM dithiothreitol, 12 ml of 0.8 M Tris-HCl buffer (pH 8.6), 25 ml of 16 mM 4-MNA, 50 ml of 0.4 mM SAM in 0.1 mM of sulfuric acid and 100 ml of enzyme preparation. The mixture was incubated at 37°C for 80 min. Substrate N-methylation proceeded linearly during the incubation period. The enzyme reaction was terminated by heating in boiling water for 2 min. The same procedure was used to prepare the blank; however, the reaction was stopped immediately without incubation. These reaction mixtures were centrifuged at 10,000 × g for 5 min at room temperature. A 100 ml aliquot of the supernatant was poured into a 1.5-ml stopper test tube with the addition of 1 ml of 0.02 M 4-methoxybenzaldehyde in 35% (v/v) aqueous 2-methoxyethanol and 100 ml of 0.5 M aqueous sodium hydroxide. The tube was heated in a water bath (100 o C) for 15 min. After cooling, the fluorescence intensity was measured using a Perkin Elmer LS50B spectrofluorometer with excitation at 418 nm and emission at 490 nm.
The quantity of the reaction product obtained, 1,4-DMN, was calculated by the calibrating curve for 1,4-DMN at the concentration range of 0.2-2.0 nM. At this range of concentration, the calibrating curve was linear. The activity of N-methyltransferase was expressed in pmol/min/mg of protein.
Determination of the concentration of MNA and its metabolites in plasma
The concentrations of endogenous MNA and its metabolites in plasma samples were measured using liquid chromatography mass spectrometry (LC/MS), as described by S³omiñska et al. [41] . Chromatographic separation was performed using a 3 mm Hypersil C18-BDS 150 × 2.0 mm column. The mobile phase A consisted of 10 mM nonafluoropentanoic acid (NFPA) in water, while mobile phase B consisted of 100% acetonitrile. The mobile phase was delivered at 0.2 ml/min in a gradient from 0% to 60% B in 12 min. The mass detector (Thermo-Finnigan LCQ Advantage, Waltham, MA, USA), which contains an electrospray ion source (ESI), was set to a positive single ion monitoring (SIM) mode to detect [M+H] + species of NA, MNA, Met-2PY, Met-4PY and a collision energy set at 25%. The internal standard (2-chloroadenosine) signal was extracted from full MS mode. The electrospray cone voltage was set at 4.5 kV, while the heated capillary temperature was set at 275°C. Sheath gas flow was set at 35 arbitrary units. Ion optic parameters were optimized using standard instrument procedures during the nicotinamide infusion. Mouse plasma was deproteinized using 10% trichloroacetic acid, which was subsequently extracted using diethyl ether. There was a 75-95% recovery of Met-2PY, Met-4PY, and NA, which was added to the samples.
The coefficient of variation was below 10% for repeated injections on the same day [40] .
Statistical analysis
Results are expressed as the means ± SD. Comparison of the means was assessed by ANOVA and post hoc Scheffe's tests. The non-parametric Mann-Whitney test was used for the analysis of data regarding the quantification of atherosclerosis, NNMT activity, and metabolite concentrations. Differences between means were considered significant at p £ 0.05. Statistical analysis was performed using Prism 5 ver. 5.01 (GraphPad Software Inc.).
Results
Progression of atherosclerosis and vascular inflammation
Atherosclerotic lesions were not detected in the aortic roots of 2-month-old apoE/LDLR -/-mice, as evidenced by the lack of Oil-Red O staining, CD68 immunostaining, and negligible gelatinase activity in in situ zymography (MMP-2/MMP-9) (Fig. 1) . However, in the intima of the aortic roots in 3-month-old apoE/LDLR -/-mice, lipid deposition, macrophage accumulation, and increased gelatinase activity were easily detected. In 4-month-old apoE/LDLR -/-mice, atherosclerotic plaques in the aortic roots were considerable in size (Oil-Red O; 3.35 ± 1.41 mm 2 × 10 5 ) and continued to increase in the later stages of plaque development in 6-month-old mice (Fig. 1) . It is interesting to note that CD-68 positive macrophages constituted the major component of the area of atherosclerotic plaques at the early stage of plaque development, while in 4-and 6-month-old apoE/LDLR -/-mice, macrophage content comprised a smaller component of the total lesion area stained by Oil-Red O (Fig. 1) . Gelatinase activity detected by in situ zymography increased gradually in the aortic roots between 3-and 6-month-old ApoE/LDLR -/-mice (Fig. 1) . As shown in Figure 2 , gelatinase activity only partially co-localized with CD68 immunostaining. These data suggest that apart from CD68 positive macrophages, other cell types were responsible for increased gelati- -g ) and 6-month-old apoE/LDLR -/-mice. Limited colocalization between CD68-immunoreactive macrophages (2e,f, arrows) and metalloproteinase activity (2 e,g, arrowheads) is evident nase activity within the plaque area, or that gelatinase activity was present extracellularly.
Changes in hepatic NNMT activity
Hepatic NNMT activity was elevated in 2-month-old apoE/LDLR -/-mice, as compared to age-matched C57BL/6J mice (1.03 ± 0.14 vs. 0.64 ± 0.23 pmol/ min/mg in apoE/LDLR -/-and wild-type mice, respectively). Furthermore, in contrast to wild-type C57BL/6J mice, where NNMT activity remained similar in 2-, 3-, 4-and 6-month-old animals, NNMT activity gradually increased with animal age in apoE/LDLR -/-mice (Fig. 3) . Hepatic NNMT activity was enhanced approximately five-fold in 6-month-old apoE/LDLR -/-mice (2.29 ± 0.34 pmol/min/mg), with advanced atherosclerotic plaques.
Changes in the concentration of NA, MNA, Met-2PY and Met-4PY in plasma
In wild-type mice plasma concentrations of NA, MNA, Met-2PY, and Met-4PY were not significantly altered by age (Fig. 4) . Interestingly, plasma concentrations of NA and MNA were elevated approximately two-fold in 2-month-old apoE/LDLR -/-mice, as compared to age-matched C57BL/6J control mice (NA; 7.92 ± 2.61 vs. 3.11 ± 0.80 mmol/l, MNA; 0.30 ± 0.13 vs.
0.17 ± 0.04 mmol/l in apoE/LDLR -/-and C57BL/6J mice, respectively). The elevations in plasma concentrations of NA and MNA were more pronounced in older apoE/LDLR -/-mice. At the age of 6 months, NA and MNA concentrations were approximately five times greater in comparison with age-matched wildtype mice (NA; 12.46 ± 1.57 vs. 4.96 ± 0.52 mmol/l, MNA; 1.08 ± 0.34 vs. 0.17 ± 0.04 mmol/l in apoE/LDLR -/-and C57BL/6J mice, respectively). In addition to the elevated plasma concentrations of NA and MNA, the levels of Met-2PY and Met-4PY in plasma were also significantly elevated in 6-monthold apoE/LDLR -/-mice, as compared to wild-type mice (Fig. 4) .
Discussion
In the present work we demonstrated for the first time, that NMMT activity and endogenous MNA levels were elevated in the early phase of atherosclerotic development and increased gradually with the progression of atherosclerosis in apoE/LDLR -/-mice.
The progression of atherosclerotic lesions in apoE/LDLR -/-mice has been well characterized [12, 21] . It is known that total-and LDL-cholesterol levels are highly elevated in apoE/LDLR -/-mice at an early age [21] , resulting in the formation of atherosclerotic lesions in the aortic roots and other regions in an agedependent manner. These lesions are characterized by numerous biochemical, structural, and functional changes resembling human pathology, including oxidized lipid accumulation, endothelial dysfunction, and vascular inflammation [20, 21, 23] .
In this study, we assessed vascular inflammation in atherosclerotic plaques by CD68 immunostaining, which reflects subendothelial macrophage accumulation. In addition, we assessed the activity of MMP-2 and MMP-9 by in situ zymography via the gelatinase assay. Both MMP-2 and MMP-9 play a major role in degradation of the vascular extracellular matrix (ECM) [17] , and their biological activity may be linked to the activation of macrophages, T lymphocytes, smooth muscle cells, and endothelial cells [25] . We found that macrophages constituted the major component of plaque area in the early stages, with other cell types and non-cellular components dominating at later stages. Interestingly, gelatinase activity was not solely associated with CD68-positive macrophages. Therefore, the increased activity of MMP-2/ MMP-9 may reflect inflammatory activation of various cell types within atherosclerotic plaques, as well as the deposition of enzymes in the extracellular matrix. As such, the assessment of gelatinase activity provides a relatively easy and comprehensive marker of vascular inflammation in atherosclerotic vessels. This notion stays in line with the important role of MMP-2 and MMP-9 in the initiation and progression of high cholesterol-driven vascular inflammation and atherosclerosis [11] .
Here, we confirmed that the development of atherosclerotic plaques in the aortic roots of apoE/LDLR -/-mice could be detected in 3-month-old animals; but not in 2-month-old apoE/LDLR -/-mice [21] . Indeed, 2-month-old apoE/LDLR -/-mice displayed no lipid deposition (as assessed by Oil Red-O) or sub- endothelial macrophage accumulation (CD68 staining), and negligible gelatinase activity (assessed by in situ zymography). However, NNMT activity and MNA plasma concentrations were elevated during the early stage of atherosclerotic development. Additionally, NO-dependent endothelial function in the aorta was impaired as early as 2 months, which was associated with ultrastructural signs of endothelial activation and hypertrophy [12] . Thus, early activation of an NNMT-dependent pathway for MNA formation coincided with the development of endothelial dysfunction in aorta, which occurred before the formation of atherosclerotic plaques in this model. Subsequently, hepatic NNMT activity and MNA plasma concentrations increased in association with the development of vascular inflammation in the aorta.
The increase in MNA plasma concentration was associated with the significant elevations in NA plasma concentrations, as well as MNA metabolites, such as Met-2PY and Met-4PY. Accordingly, the upregulation of NNMT activity may be linked to concomitant changes in the activity of NA-generating enzymes and/or to the increased catabolism of NAD + [7] , as well as changes in the activity of aldehyde oxidase, which catalyzes MNA degradation. Additionally, elevations in plasma concentrations of MNA and Met-2PY/Met-4PY in particular may depend on renal function, as these metabolites are renally excreted. Nevertheless, our results suggest a correlation between the development of vascular inflammation in atherosclerosis and MNA formation by NNMT in the liver.
Interestingly, it was recently proposed that enhanced NNMT activity induced by barbiturates may deplete pyridine nucleotides (NAD + , NADH, NADP + , NADPH) and attenuate pyridine nucleotidedependent protective systems, including NADPHdependent GSH peroxidase and GSSG reductase [16] . However, this seems unlikely to occur in the livers of atherosclerotic mice. Although the pyridine nucleotide content of the liver was not measured in the present work, it was found that GSH peroxidase activity was increased rather than decreased in the livers of apoE/LDLR -/-mice, while GSSG reductase activity was unchanged (data not shown).
Previous studies have linked the biological activity of NNMT to hyperhomocysteinemia [32] . It is known that SAH and SAM are important intermediates in the synthesis of homocysteine. Although we did not measure plasma homocysteine concentrations, it is unlikely that plasma homocysteine levels of apoE/LDLR -/-mice fed chow (but not methionine-rich) diet [43] would be altered, despite the upregulation in NNMT activity.
Previous studies have also linked the increased NNMT activity to the pathogenesis of Parkinson's disease [29] and tumor growth, migration, and metastasis [38, 46] . Based on the results of this study, we believe that elevated NNMT activity in the liver and other tissues may not be detrimental but that it may promote a compensatory anti-atherosclerotic response. This may be supported by the profile of exogenous MNA's pharmacological activity, including antithrombotic and anti-inflammatory effects mediated by the COX-2/PGI 2 pathway [8, 10] . MNA was also shown to reverse endothelial dysfunction and to affect lipid metabolism, but the involvement of the COX-2/PGI 2 pathway was not examined in this regard [5] .
It is obvious that MNA concentrations in MNAtreated animals [5] exceed endogenous MNA plasma concentrations in this study. Still considering the well-known vasoprotective and anti-atherosclerotic properties of the COX-2/PGI 2 pathway [18, 19] and increased vascular PGI 2 synthesis in apoE LDLR -/-mice [12] , it is tempting to speculate that NNMTderived MNA may activate vascular COX-2/PGI 2 pathway in atherosclerosis.
We did not investigate the mechanisms involved in the upregulation of NNMT activity. It is possible that hepatic NNMT is regulated by IL-6 and STAT-3-dependent mechanisms [42] . In fact, pro-inflammatory factors released by the activated endothelium or vascular wall [1, 20] may provide the stimulus for increased NMMT activity in the liver. If this is true, NNMT activity could represent a novel component of the liver's response to atherosclerosis.
In summary, our study demonstrated that the progression of vascular inflammation and atherosclerosis in apoE/LDLR -/-mice is associated with increased hepatic NNMT activity, coupled with elevated levels of plasma MNA concentrations. Further studies are necessary to verify whether this response is biologically significant and represents an endogenous antithrombotic and anti-inflammatory pathway in atherosclerosis.
